Recently, Yokoyama et al. [10] described an interesting case in which both an MLH1 germline variant and MLH1 promoter hypermethylation were observed in endometrial cancer in the same patient and concluded that LS cannot be excluded even if MLH1 promoter hypermethylation on tumoral tissue is observed. The gene discussed is MLH1; the disease is endometrial cancer.